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CD4CD25 Immunoregulatory T Cells: Gene
Expression Analysis Reveals a Functional Role
for the Glucocorticoid-Induced TNF Receptor
analysis of the functional properties of the CD4CD25
subset (Thornton and Shevach, 1998; Takahashi et al.,
1998). CD4CD25 T cells are anergic when stimulated
via their TCR but proliferate when costimulated with IL-2.
Importantly, CD4CD25 T cells inhibit the proliferative
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sion requires stimulation of the CD4CD25 T cells viaNational Institutes of Health
their TCR and, in contrast to the in vivo studies, is medi-Bethesda, Maryland 20892
ated exclusively by a cell contact-dependent, cytokine-2 Genetics Institute/Wyeth Research
independent mechanism. Once activated, CD4CD25Cambridge, Massachusetts 02140
T cells acquire nonspecific suppressor activity and this
suppressive function is maintained in the absence of
further stimulation via the TCR (Thornton and Shevach,Summary
2000). As suppression is only observed upon activation
of the CD4CD25 cells, this suggests that TCR activa-CD4CD25 immunoregulatory T cells represent a
tion induces the expression of a cell surface protein(s)unique lineage of thymic-derived cells that potently
that mediates suppressor function by binding to its re-suppress both in vitro and in vivo effector T cell func-
ceptor(s) constitutively expressed or induced on the re-tion. We analyzed CD4CD25 and CD4CD25 T cells
sponder cells by antigen stimulation.by DNA microarray, identifying 29 genes differentially
Very little is known about the requirements for theexpressed in the resting subpopulations, and 77 that
development and physiologic regulation of CD4CD25were differentially expressed following activation.
T cell function in vivo. The survival and/or expansion ofMost of these genes were elevated in the CD4CD25
the CD4CD25 population in the periphery appears topopulation, suggesting a previously activated pheno-
require the availability of IL-2, as mice deficient in IL-2type. Among these were a number of genes that antag-
(Papiernik et al., 1998), components of the IL-2R (CD25,onize signaling, including members of the SOCS fam-
CD122), as well as cell surface antigens that play criticalily, which may contribute to their anergic phenotype.
roles in the costimulation of IL-2 production (CD80/Multiple cell surface receptors also had increased ex-
CD86, CD28, and CD40) (Salomon et al., 2000; Kumano-pression in CD4CD25 cells, including GITR, a mem-
goh et al., 2001) manifest major deficiencies in theber of the TNF receptor superfamily. Importantly, anti-
CD4CD25 T cells. Some of these mice also developbodies to GITR abrogated suppression, demonstrating
lymphadenopathy, hyperproliferation, and autoimmu-a functional role for this receptor in regulating the
nity that may be a direct result of the deficiency inCD4CD25 T cell subset.
CD4CD25 T cells.
Taken together, both the in vivo and in vitro studiesIntroduction
strongly support the view that the CD4CD25 popula-
tion represents a unique lineage of regulatory T cells.Thymic-derived regulatory T cells have been shown to
However, CD25, the most suitable marker for identifica-be critical in the regulation of self-reactive T cells in the
tion of this population, is also expressed by all recentlyperiphery (Shevach, 2000). These cells represent a small
activated T cells. Although the mere acquisition of CD25
population (10%) of CD4 T cells constitutively express-
expression does not induce the suppressor phenotype
ing the  chain (CD25) of the IL-2R complex (Sakaguchi
(Suri-Payer et al., 1998; Thornton and Shevach, 2000),
et al., 1995). Transfer of CD4CD25 T cells readily in- it is difficult to rule out the possibility that this population
duced the development of autoimmune disease in immu- of T cells, constitutively expressing CD25, also contains
nodeficient recipients and cotransfer of CD4CD25 cells a certain percentage of normal activated or memory
suppressed the development of disease. CD4CD25 T cells. Furthermore, it is also unknown whether the
cells were also shown to prevent autoimmune disease expression of CD25 is stable in vivo, if induction of CD25
induced by thymectomy of certain strains of mice on under certain conditions may generate the suppressor
day 3 of life, as well as to inhibit the capacity of both phenotype, or how CD4CD25 T cells are related to
autoreactive Th1 and Th2 clones to induce autoimmune other immunoregulatory T cells that function primarily
gastritis (Suri-Payer et al., 1998, 1999). CD4CD25 by producing the suppressor cytokine, IL-10 (Groux et
T cells appear to inhibit the development of autoimmune al., 1997; Cottrez et al., 2000; Jordan et al., 2000).
disease by both cytokine-dependent (Asseman et al., We have employed DNA microarray technology to
1999; Seddon and Mason, 1999) and cytokine-indepen- compare patterns of gene expression in CD4CD25
dent pathways (Suri-Payer and Cantor, 2001; McHugh and CD4CD25T cells. This technique allows a system-
et al., 2001). atic analysis of gene expression differences between
Development of in vitro model systems has facilitated cell groups with a single hybridization (Staudt and
Brown, 2000). It has proven to be very valuable in the
analysis of differences that occur upon malignant trans-3 Correspondence: eshevach@niaid.nih.gov (E.M.S.), marycollins@
genetics.com (M.C.) formation of cells (Alizadeh and Staudt, 2000), following
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Figure 1. Genes Differentially Expressed between Resting CD4CD25 and CD4CD25 T Cells
Two independent isolations of lymph node T cells were sorted for expression of CD4 and either the presence or absence of CD25. RNA was
isolated and analyzed on DNA microarrays. mRNA frequency values (mRNA molecules per million) are displayed for genes differentially
expressed in both replicates.
infection of a population with a pathogen (Ichikawa et Results
al., 2000), or after disease onset (Wilson et al., 2000).
Our goals in the application of this technology were Comparison of Gene Expression in Resting
CD4CD25 and CD4CD25 T Cells3-fold: (1) the identification of genes differentially ex-
pressed by resting CD4CD25 T cells whose products by DNA Microarray Analysis
CD4CD25 T cells have been distinguished frommight be used to develop more specific reagents to
facilitate functional studies; (2) analysis of differential CD4CD25 T cells on the basis of a small number
of differentially expressed cell surface markers (Shevach,gene expression at two time points following TCR acti-
vation to search for molecules (cell surface or secreted) 2000). To further characterize CD4CD25 T cells, we
compared the results of hybridization of two independentthat may be involved in the effector phase of suppres-
sion; and (3) determination of genes expressed in the isolations of RNA from CD4CD25 and CD4CD25
T cells to DNA microarrays that monitor the expressionresting or activated state of CD4CD25 cells that may
maintain their anergic phenotype. We find that only a of 11,000 murine genes and ESTs. Genes differentially
expressed between the two resting populations in bothsmall number of genes (29) are differentially expressed
between the resting CD25 and CD25 T cells and that a replicates are shown in Figure 1. Of the 29 genes identi-
fied, 21 genes were expressed at higher levels and 8larger number (77) are differentially expressed following
activation. Nine of these genes are shared between the were expressed at lower levels in resting CD4CD25
cells relative to resting CD4CD25 T cells.resting and activated state, making the total number of
genes differentially expressed 97. One gene encodes a A wide variety of functional gene classes are repre-
sented, including cell surface receptors, secreted mole-cell surface receptor that appears to be involved in the
generation of suppressor effector function and several cules, transcription factors, signaling molecules, small
G proteins, and kinases, in addition to a number of un-genes encode factors that may be related to the anergic
state of CD4CD25 cells. characterized ESTs. Eight cell surface receptors were
DNA Microarray Analysis of CD4CD25 T Cells
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Figure 2. Kinetic Expression Patterns of Genes Differentially Expressed between CD4CD25 and CD4CD25 T Cells after Stimulation
Two independent purifications of CD4CD25 and CD4CD25 T cells were stimulated with plate-bound anti-CD3 and IL-2 for 12 or 48 hr.
RNA was isolated and analyzed on DNA microarrays. (A) Genes differentially expressed in both replicates at either one or both of the two
stimulation time points were selected for clustering analysis using the self-organizing map (SOM) algorithm. Hours of anti-CD3 stimulation
are indicated on the x axis and normalized mRNA frequency (a log transformation of absolute frequency values, which allows clustering
independent of expression magnitude) is displayed on the y axis. Genes populating each of the four clusters are listed in Table 1. (B) Kinetic
mRNA expression of CD25 and GITR was analyzed for CD4CD25 and CD4CD25 T cells at the 0, 12, and 48 hr time points for the two
independent purifications and stimulations.
differentially expressed, including three members of the shown), consistent with the differential protein ex-
pression.TNF receptor superfamily (TNFRSF). CTLA-4 (CD152),
Galectin-1, CD103, Ly6, Glucocorticoid-induced TNF re-
ceptor (GITR/TNFRSF18), OX-40 (CD134/TNFRSF4), and Identification of Genes Differentially Expressed
in CD4CD25 T Cells upon Activation4-1BB (CDw137/TNFRSF9) had increased mRNA levels
in the CD4CD25 T cells, whereas TCR  chain had Immunoregulatory activity of CD4CD25 T cells is de-
pendent upon stimulation through the TCR. Preactiva-decreased mRNA levels in the CD4CD25 T cells. In
addition, LEF-1, a transcription factor that binds to the tion of CD4CD25 T cells, for a minimum of 2 days
with anti-CD3 and IL-2, results in the generation of aTCR enhancer to regulate expression (Okamura et al.,
1998), was also expressed at lower levels in CD4CD25 suppressive bioactivity that is TCR nonspecific and sta-
ble for several weeks. To identify genes whose productsT cells. Although CD25 surface expression is readily
detected by flow cytometry, CD25 mRNA levels were may contribute to this functional activity, we compared
RNA isolated from CD4CD25 and CD4CD25 T cellsnot identified as increased in comparison to the CD25
subset, suggesting that levels of transcription for CD25 after stimulation for 12 or 48 hr from two independent
purifications. Genes identified as increased or de-in resting CD4CD25 cells are below the detection lim-
its of the arrays. In agreement with this interpretation, creased in expression after activation in both replicates
were included for further analysis. Of 11,000 genes andsemiquantitative PCR revealed an 11-fold increase in
RNA transcription of CD25 in the CD25 subset com- ESTs analyzed, approximately 1500 responded similarly
to stimulation in both subsets of cells (data not shown).pared to the CD25 subset in the resting state (data not
Immunity
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Table 1. Genes/ESTs Differentially Expressed between CD4CD25 and CD4CD25 T Cells after Stimulation with Anti-CD3 and IL-2
Functional Category Accession Number Common Name Clustera
Secreted
M16762 IL-2 1
U28493 Lymphotactin 1
M37897 IL-10 2
U43088 IL-17 2
L33416 ECM-1 2
M13227 Enkephalin 2
M17015 Lymphotoxin 3
X12531 MIP-1 4
M35590 MIP-1 4
X51834 ETA-1 4
Surface Receptor
L38971 ITM-2 1
M28052 IL2R 2
M80481 GIR 2
X16834 Mac-2 2
U18797 H-2M3 2
X06143 CD2 2
K02891 IL2R 3
L29441 TMS-1 3
U82534 GITR 3
X85214 OX40 3
U04268 Ly-6 3
X03151 Thy-1 3
X66532 Galectin-1 4
Signaling
L16956 JAK-2 1
M25811 PKC- 2
AF001863 SLAP-130 2
U88327 SOCS-2 2
D31943 CIS 3
AB000677 JAB 3
Nucleotide Metabolism
AA407018 Thy. DNA glycos. 1
X17459 J RS BP 3
M14223 Ribo. reductase 4
General Metabolism
L25885 GM2/GD2 Synth. 1
U59488 p40-phox 2
AA186047 Glutaredoxin 3
AF030343 Ech-1 3
X61600 -enolase 3
AA174394 Phos.inos.glyc. 3
M26270 SCD-2 4
Transcription Factor
U43788 OBF-1 1
M12848 Myb 2
M60285 CREM 2
U06924 STAT-1 2
AA048098 B-Myc 2
AF027963 XBP-1 3
Protein Metabolism
AA008321 Prot. Comp. C9 1
X71642 GEG-154 1
AA118121 Isoleu. tRNA Synth. 1
AA396357 Ubiq. Conj. Enz. 2
M65270 Cathepsin B 2
X95818 Synaptophysin 2
D85561 Prot. Sub. MECL-1 3
L11145 Prot. Sub. LMP-7 3
L11613 Prot. Sub. LMP-2 3
M64085 Spi-2 3
M12302 Granzyme B 4
Small G Protein/Cytoskeleton
U72519 Ena-VASP 1
AAAA415898 IIGP 2
U05245 TIAM-1 2
U44731 GBP-3 2
(continued)
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Table 1. Continued
Functional Category Accession Number Common Name Clustera
Calcium
M37761 Calcyclin 2
M16465 Calpactin I 2
M96823 Nucleobindin 3
Cell Cycle
AA138777 GADD45- 3
X58708 Cyclin B 4
Unknown
AA620163 EST 1
AA163876 EST 2
AA289168 EST 2
AA726223 EST 2
U13371 EST 2
U38196 Palmityol.p55 2
W08322 EST 2
W98255 EST 3
C78378 EST 3
AA016708 EST 3
W10606 EST 3
AA117227 EST 4
a Genes/ESTs populating the four expression clusters of Figure 2 are listed by functional class.
In contrast, only 77 genes were significantly and repro- cated as activation markers. The activation markers IL-
2R (CD25), IL-2R, CD2, and OX-40, although inducedducibly differentially expressed after activation between
CD4CD25 and CD4CD25 T cells, and these genes upon activation in the CD25 subset, are more highly
induced in the CD25 subpopulation. In addition, weshowed similar expression patterns in both experiments
at all three time points. These genes were clustered reproducibly observed upregulation of Glucocorticoid
induced receptor (GIR), a G protein coupled receptorusing the self-organizing map (SOM) algorithm, a statis-
tical method for grouping genes based on expression (Harrigan et al., 1991) whose ligand is unknown, and
GITR, a TNFRSF member, that when engaged by itspatterns independent of expression magnitude (Tamayo
et al., 1999) (Figure 2A). Four basic patterns of expres- ligand (GITR-L), causes activation of the NF-B pathway
and protection from apoptosis (Gurney et al., 1999; No-sion in the CD25 subset relative to CD25 subset were
revealed. Cluster 1 contains genes that are induced al- centini et al., 1997). The levels of induction of both CD25
and GITR in CD4CD25 and CD4CD25 T cells aremost exclusively in the CD25 subset at 12 hr, but for
which induction is transient, with expression levels displayed in Figure 2B.
A number of mRNAs for secreted molecules were in-dropping to baseline by 48 hr. This group includes mole-
cules characteristic of the productive immune response, duced to a higher level in the CD25 subpopulation,
including the chemokines MIP-1 and MIP-1, whichincluding IL-2, lymphotactin, and JAK-2. The lack of
induction of these mRNAs in the CD4CD25 T cells is are involved in cellular recruitment to sites of immune
activation (Moser and Loetscher, 2001) and have beenconsistent with an anergic phenotype. The other three
clusters contain genes preferentially expressed at a reported to be expressed in anergic cells (Lerner et al.,
2000). In addition, the inflammatory protein IL-17 andhigher level in CD25 cells relative to CD25 cells. Clus-
ter 2 identifies genes that are exclusively induced in the the immunosuppressive cytokine IL-10 exhibited an in-
crease in expression in the CD25 subset following acti-CD25 subpopulation at 12 hr, with expression returning
to baseline by 48 hr. Cluster 3 contains genes that are vation. mRNA for enkephalin, a neuropeptide shown to
be expressed in Th2 cells (Yahata et al., 2000), waselevated in the CD25 subpopulation at 12 hr and remain
elevated at the 48 hr time point. The genes in cluster 4 elevated after 12 hr of stimulation in CD4CD25 T cells.
We also observed elevated induction of early T cell acti-are elevated in CD25 cells, but only at the later time
point. Of the genes found to be differentially expressed vation-1 (ETA-1), a cytokine reported to regulate the
expression of IL-12 and IL-10 in macrophages (Ashkarbetween CD25 and CD25 cells, 84% (65/77) were ele-
vated in the CD25 subset. Table 1 lists the genes and et al., 2000). mRNA for extracellular matrix protein-1
(ECM-1), an 85 kDa secreted protein that possessesfunctional classes populating the four clusters.
CD4CD25 T cells have certain markers characteris- angiogenic activity (Han et al., 2001) and has not pre-
viously been reported in immune cells, was consistentlytic of memory/activated T cells, particularly CD45RBlow
(Thornton and Shevach, 2000) and CTLA-4 (Read et al., induced in the CD25 subset.
Activated CD4CD25 cells also expressed high lev-2000; Takahashi et al., 2000). The propensity of the
CD25 subpopulation to upregulate so many genes els of mRNA for factors that play important roles in
downregulation of cytokine production and cytokineupon activation of the T cell receptor is consistent with
a previously activated/memory phenotype. This is sup- mediated activation. Several members of the suppres-
sors of cytokine signaling family (Chen et al., 2000) CIS,ported by the heightened expression of a group of cell
surface receptors, several of which have been impli- SOCS-1/JAB, and SOCS-2, were expressed at higher
Immunity
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Figure 3. Resting and Activated CD4CD25 T Cells Have Increased Protein Expression of Cell Surface Receptors
Freshly isolated peripheral lymph node cells, stained for CD4 and CD25, were analyzed for cell surface expression of GITR, OX40, 4-1BB,
CD103, and CTLA-4. CD4CD25 and CD4CD25 cells were purified and stimulated for 48 hr with plate-bound anti-CD3 and IL-2. These
cells were stained for CD4 and CD25 and analyzed for expression of GITR, OX40, 4-1BB, CD103, and CTLA-4. The various cell subsets were
compared to their isotype control Ig and analyzed by CellQuest software for percent positive expression. The CD25 to CD25 mean
fluorescence intensity ratio is indicated to the right of each group of histograms.
levels in CD4CD25 cells. Another signaling molecule CD103, an integrin expressed by intraepithelial lympho-
cytes (IEL) (Agace et al., 2000), was expressed on 20%–elevated in the CD25 subset was SLAP130, shown to
30% of CD4CD25 cells, and was not found on thehave a negative regulatory effect on SLP-76/NFAT en-
CD25 subset. Although the percentage of cells ex-hanced IL-2 production (Musci et al., 1997). The expres-
pressing 4-1BB on the cell surface was not dramaticallysion of these proteins may account, in part, for the failure
different between to the two subsets, the MFI was higherof the CD25 cells to produce IL-2.
in the CD4CD25 cells in the resting state. Differential
expression of Ly6 genes was detected in the CD25
Differential Expression of Cell Surface Receptors subpopulation; however, we found that only Ly6A/E
Differential mRNA expression for cell surface molecules (Sca-1) was preferentially expression on the cell surface
was extended to the protein level using flow cytometry. of resting CD4CD25 T cells (data not shown).
Comparison of CD4CD25 and CD4CD25 cells As expected, molecules expressed on activated
showed that the molecules GITR, OX40, and CTLA-4 T cells (GITR, 4-1BB, OX40, and CTLA-4) were upregu-
were expressed at a higher level on resting CD4CD25 lated on both cell populations after 48 hr of stimulation
cells (Figure 3 left panels, CD25/CD25 mean fluores- with plate-bound anti-CD3 and IL-2 (Figure 3 right pan-
cence intensity (MFI) ratio 3.6, 3, and 2.2, respectively). els). The levels of GITR, OX40, 4-1BB, and CTLA-4, how-
In addition to the previously reported constitutive ex- ever, were elevated on CD25 cells, even after activation
pression of CTLA-4 by the CD4CD25 subpopulation (CD25/CD25 MFI ratio, 1.6, 2.2, 4.5, and 3.6, respec-
of T cells, only CD4CD25 cells expressed the TNFRSF tively). Ly6 was also induced on both subsets, with Ly6A/E
still being expressed at a higher level on the CD25 cellsmembers GITR and OX40 without in vitro activation.
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317
(data not shown). Interestingly, the expression of CD103
was not significantly upregulated after activation for 48
hr, and the percentage of CD4CD25 cells that ex-
pressed CD103 in the resting and activated state was
comparable (Figure 3).
Separation of CD4CD25 Cells by CD103 Expression
Since the discovery that CD4 cells expressing CD25
were capable of exerting a suppressive effect in vivo and
in vitro, many groups have worked to find another marker
to identify these cells. We previously attempted to func-
tionally subdivide CD4CD25 cells based on the differ-
ential expression of CD45RB, CD62L, CD69, and CD38
(Thornton and Shevach, 2000); however, all subpopula-
tions were equally suppressive when tested in vitro. As
CD4CD25 cells also displayed a bimodal pattern of
expression of CD103, it was of interest to test whether
CD103CD25 and CD103CD25 cells would exhibit
activity in an in vitro suppression assay. CD4CD25
cells were sorted based on the highest and lowest 20%
of CD103 expression (Figure 4A) and tested functionally
in an in vitro suppression assay with CD4CD25 re-
sponding T cells (Figure 4B). Both CD103CD25 and
CD103CD25 cells were able to suppress anti-CD3
induced proliferation of CD4CD25 T cells. Consis-
tently, however, the CD103CD25 cells were more effi-
cient, on a per cell basis, at suppressing the proliferation
of the responders. In addition, CD4CD103 cells, with-
out selection for CD25, were able to suppress in vitro
proliferation (data not shown). Analysis of CD103CD25
cells revealed that they have a phenotype of recently
activated cells, showing higher levels of CD69 and lower
levels of CD45RB and CD62L by flow cytometry than
CD25CD103 T cells (data not shown). Acquisition of
suppressive activity was independent of CD103 expres-
sion, as CD25CD103 cells, although suppressive, did
not express CD103 upon activation (data not shown).
Reversal of Suppression with Anti-GITR Antibody
Analysis of differential expression using DNA microar-
rays identified many candidate genes that may be in-
volved in the suppressive function of the CD4CD25
cells or involved in the acquisition/regulation of the sup-
pressive phenotype. As monoclonal or polyclonal anti-
bodies are available for many of the products of the
differentially expressed genes, we tested the capacity
Figure 4. Suppression by CD4CD25 Cells Does Not Segregateof these antibodies to reverse suppression in cocultures
with CD103 Expressionof CD4CD25 and CD4CD25 T cells. Antibodies to
(A) CD4CD25, CD4CD25CD103, and CD4CD25CD103CD103, CTLA-4, 4-1BB, OX40, CD2, IL-17, and IL-17R
T cells were cell sorted as described in Experimental Procedures(10g/ml) had no effect on the ability of the CD4CD25
and (B) cocultured with CD4CD25 T cells in the presence of 0.5cells to exert suppression (data not shown). In contrast,
g/ml anti-CD3 and irradiated T cell depleted splenocytes. This
a polyclonal Goat antiserum to the mouse GITR extracel- figure is representative of four independent experiments.
lular domain was able to reverse suppression induced by
freshly isolated CD4CD25 cells from normal BALB/c
animals in response to anti-CD3 (Figure 5A). The speci- reverse CD25 mediated suppression of the activation
of CD8 cells. These results are identical to those seenficity of this polyclonal antibody for mouse GITR was
confirmed by staining of Cos cells transfected with the with CD4 responders (Figure 5C).
We next evaluated the capacity of anti-GITR to reversemouse GITR cDNA (data not shown). In addition, anti-
GITR reversed the capacity of CD4CD25 T cells iso- suppression by CD25 T cells that had been preacti-
vated to confer the suppressive phenotype (Figure 5D).lated from HA Tg mice to inhibit the responses of HA
Tg CD4CD25 T cells to their specific peptide (Figure Reversal of suppression in the response to anti-CD3
was consistently observed in these studies, but only at5B). As CD25 T cells can also suppress the responses
of CD8 T cells, we also tested whether anti-GITR could lower numbers of CD4CD25 T cells. Suppression was
Immunity
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Figure 5. Polyclonal Antibodies to GITR Reverse Suppression Mediated by Fresh CD4CD25 T Cells, but Do Not Prevent Induction of
Suppressive Activity
CD4CD25 and CD4CD25 T cells were purified from (A) BALB/c or (B) HA Tg mice and cocultured in the presence of (A) anti-CD3 or (B)
HA(110-120) and irradiated T cell depleted splenocytes. CD8 T cells were also cocultured with CD4CD25 T cells (C) in the presence of anti-
CD3 and irradiated T cell-depleted splenocytes. BALB/c CD4CD25 T cells were also purified and prestimulated for 3 days in the presence
of soluble anti-CD3, IL-2, and irradiated T cell depleted splenocytes. These cells were washed and cocultured with (D) BALB/c CD4CD25
T cells in response to anti-CD3 or (E) HA Tg CD4CD25 T cells in response to HA(110-120). Suppression assays were cultured in media alone
or in the presence of 2 g/ml Control Goat Ig (open diamonds) or Goat anti-GITR (closed circles). For (F) and (G), CD4CD25 T cells were
preactivated for 3 days with soluble anti-CD3, irradiated T cell depleted splenocytes, and IL-2. During the preactivation step the cells were
cultured without antibody (open squares), in the presence of 2 g/ml control Goat IgG (open diamonds), or Goat anti-GITR (closed circles).
These cells were then cocultured with BALB/c CD4 cells responding to anti-CD3 (F) or HA Tg CD4 cells responding to peptide (G). Results
are representative of three to eight independent experiments.
not abrogated at higher suppressor to responder cell T cells, although this inhibition could be overcome with
the addition of more activated suppressor cells.ratios. One difficulty in interpreting this experiment is
that the possibility remained that the preactivated A possible interpretation of these results is that the
antibody engages GITR on CD4CD25 T cells and in-CD25 T cells were restimulated by anti-CD3 in the sup-
pression assay. In order to determine whether anti-GITR hibits the induction of suppressor activity, but has mini-
mal effect once suppressor function has been induced.would reverse suppression under conditions that pre-
cluded restimulation of the activated CD25 cells in the To test this possibility, we preactivated CD4CD25
T cells from wild-type BALB/c mice with soluble anti-suppression assay, we tested the ability of anti-GITR
to reverse suppression of HA-specific CD4 T cells, in CD3, irradiated T-depleted splenocytes, and IL-2 in the
presence of anti-GITR or control GIgG. These activatedresponse to their specific peptide, by activated CD25
T cells from normal BALB/c mice (Figure 5E). Again, at cells were then tested for suppressor activity. Preactiva-
tion of CD4CD25 T cells under these conditions, how-low suppressor to responder ratios, suppression was
consistently reversed. Thus, anti-GITR treatment could ever, did not affect their subsequent ability to suppress
responding T cells where either suppressor activity wasreverse suppression mediated by preactivated CD25
DNA Microarray Analysis of CD4CD25 T Cells
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Figure 6. Anti-GITR and IL-2 Induce Proliferation of CD4CD25 T Cells
(A) Purified CD4CD25 (closed symbols) or CD4CD25 (open symbols) cells (5  104) were cultured with Goat anti-GITR and irradiated
T cell-depleted splenocytes in the presence of different doses of IL-2. (B) Purified CD4CD25 T cells were preactivated with soluble anti-
CD3, irradiated T cell depleted splenocytes and IL-2. These cells were then cultured with Goat anti-GITR in the presence of different doses
of IL-2. Results are representative of three independent experiments.
restimulated (anti-CD3, Figure 5F) or restimulation was not augmented by the presence of anti-GITR (Figure
6B). Taken together, these studies strongly favor theprecluded (HA peptide, Figure 5G).
view that the reversal of suppression by the presence
of anti-GITR is mediated by an effect of the antibodyAnti-GITR Acts on CD4CD25 T Cells, Not CD4CD25
on the CD4CD25 population.T Cells, to Enhance IL-2 Responsiveness
The results presented above are consistent with the
possibility that interaction of the antibody with GITR Discussion
on CD4CD25 T cells modulates suppressor function.
However, the flow cytometry studies (Figure 3) demon- A number of different technologies have been used to
study gene expression in different subpopulations ofstrate that GITR is also induced on CD25 T cells after
activation. It was important to rule out the possibility T lymphocytes, including subtraction techniques and
differential display (Marrack et al., 2000). Microarraythat reversal of suppression mediated by anti-GITR was
not due to engagement of GITR on the responder T cells technology has recently been used to compare patterns
of gene expression in vivo in resting T cells and followingproviding a costimulatory signal similar to anti-CD28.
While anti-CD28 increased the proliferation of the activation with superantigen (Mitchell et al., 2001), as
well as T cells that have been rendered anergic by expo-CD4CD25 cells to anti-CD3, anti-GITR had no effect
(data not shown). Treatment of CD4CD25 cells with sure to self-antigen in vivo (Lechner et al., 2001). We have
applied the microarray technology to compare gene ex-anti-GITR does not appear to allow protection from apo-
ptosis, as a similar percentage of apoptotic cells are pression in the resting and activated state of two highly
purified subpopulations of the CD4 lineage of lympho-found when culturing with anti-CD3 alone or in the pres-
ence of control Ig or anti-GITR (20, 22, and 19% respec- cytes that have different functional properties in vivo
and in vitro. While CD4CD25 lymphocytes representtively, data not shown).
Although CD4CD25 T cells express the  chain of cells that can produce IL-2, proliferate in vitro, and differ-
entiate into effector Th1/Th2 cells, CD4CD25 T cellsthe IL-2R, they are unable to proliferate even when cul-
tured with high concentrations of IL-2 (Thornton and fail to respond to stimulation via the TCR by producing
IL-2 and have the unique capacity to suppress the pro-Shevach, 1998). The nonresponsiveness to IL-2 may be
secondary to a failure of expression of the  and/or  duction of IL-2 and other effector cytokines by both
CD4 and CD8 CD25 T cells. Our studies support thechains of the IL-2 R, although mRNA for both chains is
easily detectable by real-time PCR (H. Mizuhara and view that these two populations of CD4 T cells differ
in only a small number of the 11,000 genes and ESTsE.M.S., unpublished data). Alternatively, the nonrespon-
siveness to IL-2 may be related to their anergic state tested, as well, over 1000 genes/ESTs were modulated
similarly in the two populations in response to anti-CD3and suppressive activity. We cultured CD4CD25 and
CD4CD25 T cells in the presence of anti-GITR and (data not shown), but only 97 were found to be consis-
tently differentially expressed. In addition, the patternsIL-2 in the absence of TCR stimulation. In the presence
of anti-GITR, the CD25 subpopulation (open symbols) of genes expressed in the CD25 cells are not consistent
with the hypothesis that CD25 cells simply representproliferated to both a high and low concentration of
IL-2, while the CD25 subset (closed symbols) failed a population of previously activated T cells, as many of
the observed differences are closely correlated with theto proliferate (Figure 6A). The responses of activated
CD4CD25 T cells that express both CD25 and GITR distinct functional properties of these subpopulations.
One of the goals of this study was the identificationto both low and high concentrations of IL-2 were also
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of genes that encode cell surface antigens that distin- siveness to IFN in certain cell types. As large amounts
guish the CD25 subpopulation. Several genes were of IFN may be produced during an immune response
identified that fit this description, including CTLA-4, Ly6, to an infectious agent, the capacity of the CD25 T cells
OX40, 4-1BB, CD103, and GITR. The availability of anti- to preferentially upregulate this inhibitor may diminish
bodies to all of these antigens has facilitated a compari- their suppressive function during protective immune re-
son of the mRNA data with protein expression at the sponses.
cell surface. Four antigens, OX-40, GITR, CD103, and We, along with others, have postulated that activation
CTLA-4, were readily detectable and exclusively ex- of the CD4CD25 T cells results in induction of a cell
pressed on the cell surface of resting CD4CD25, but surface molecule(s) that contributes to CD25 T cell
not CD4CD25 T cells. Several groups have previously function. We investigated the role of a number of identi-
shown that CD4CD25 T cells were the only T cells fied genes by using neutralizing antibodies to both cyto-
in the normal lymphocyte pool that expressed CTLA-4 kines and cell surface antigens that were either selec-
(Read et al., 2000; Takahashi et al., 2000). Following tively expressed on resting CD25 T cells or induced
activation, CTLA-4 is induced on the CD25 subpopula- during activation. A polyclonal Goat antiserum to GITR
tion. Indeed, OX-40 and GITR are also induced on the reversed CD25 T cell-mediated suppression, sug-
CD25 subset and thus resemble CD25 and CTLA-4. gesting that GITR plays a critical role in the suppression
Expression of CD103 was, interestingly, only ex- process.
pressed on a minor (30%) subpopulation of CD25 A comparison of the structure of GITR with other mem-
T cells, and the level of expression was not modu- bers of the TNFRSF raises the possibility that GITR may
lated by T cell activation. Both CD25CD103 and play a costimulatory role in the activation of CD25
CD25CD103 T cells were capable of inhibiting the T cell-mediated suppressor function. The murine GITR
activation of CD25 cells in vitro. This result is similar is a 228 amino acid type I transmembrane protein with
to our observation with other antigens (CD45, CD62L, three cysteine pseudorepeats in the extracellular do-
CD69, CD38) that subdivided the CD25 population. If main and resembles TNFRSF members CD27 and 4-1BB
the cells constitutively expressed CD25, they always in the intracellular domain (Nocentini et al., 1997). Impor-
inhibited T cell activation in vitro. As CD103 plays a tantly, 4-1BB and CD27 molecules provide strong co-
role in the maintenance of lymphocytes in the intestine stimulatory signals for T cell proliferation when ligated
(Schon et al., 1999), it would be of interest to compare with their respective ligands or agonistic antibodies (De-
the capacity of CD103 and CD103 T cells to suppress Benedette et al., 1997; Kobata et al., 1994). Four different
inflammatory bowel disease with their capacity to sup- splicing products of murine GITR have been identified
press autoimmune disease of another organ system. and one of the variants, GITR-B, bears a unique cyto-
The CD25 subpopulation is unique in that activation plasmic domain due to a reading frame shift (Nocentini
via the TCR fails to result in IL-2 production and prolifera- et al., 2000). A region of the GITR-B cytoplasmic domain
tion, even in the presence of potent costimulatory sig- has significant homology with the cytoplasmic region
nals such as agonistic anti-CD28. It was therefore of of CD4 and CD8 that interacts with p56lck. Thus, interac-
interest that three members of the suppressors of cyto- tion of GITR with the GITR-L, perhaps expressed on an
kine signaling (SOCS) family, CIS, SOCS-1/JAB, and APC, may deliver a signal to regulate the suppressive
SOCS-2, appeared to be more highly induced after acti- function of CD25 T cells.
vation of the CD25 T cells. As IL-2 is required for the As GITR was upregulated on the CD25 subset follow-
survival/maintenance of the CD25 population, the ing activation, it was necessary to determine whether
SOCS proteins may be induced in response to this cyto- addition of anti-GITR was mediating reversal of suppres-
kine or other cytokines needed for the homeostatic con- sion by acting on the CD25 T cell or the responding
trol of these cells. Indeed, IL-2 induces the expression CD25 T cell. Importantly, culture of the CD25, not the
of SOCS-1 (Sporri et al., 2001), perhaps resulting in neg-
CD25 T cells, with anti-GITR and IL-2 resulted in a
ative feedback in response to IL-2 through inhibition of
vigorous proliferative response. Thus, anti-GITR is capa-
STAT5 (Ram and Waxman, 1999). CIS, similar to
ble of directly inducing a signal in the CD25 populationSOCS-1, is induced by IL-2, IL-3, and erythropoietin and
that enables it to respond to IL-2. Additionally, this sug-inhibits STAT5 activation in response to these cytokines
gests that anti-GITR functions as an agonist for GITR(Chen et al., 2000). Elevated levels of SOCS expression
in this assay, providing a signal to the CD25 cells, rathermay be required to carefully control the size of the
than blocking the interaction of GITR with its ligand.CD25 population in vivo to achieve a fine balance be-
Anti-GITR was not as potent in reversal of suppressiontween the necessity to suppress autoreactivity and the
once the suppressor cells were fully activated, sug-ability to allow appropriate responses to foreign anti-
gesting that it acts by modulating the induction of sup-gens. SOCS-1 has also been shown to bind to all four
pressor cell function. Surprisingly, addition of anti-GITRJAK kinases, therefore having additional inhibitory ef-
to CD25 T cells during the preactivation phase did notfects on multiple cytokines (Chen et al., 2000). In addition
inhibit suppressor function in a subsequent responderto STAT5, SOCS-1 is also a negative regulator of STAT3
assay. Preactivation of CD25 T cells requires engage-and STAT6 activation and may play a role in regulating
ment of the TCR in the context of IL-2. Thus, high levelsresponses to IL-4 and IL-6 (Starr et al., 1997; Losman
of IL-2 during preactivation may override the effect ofet al., 1999). IFN is also a potent inducer of SOCS-1
GITR engagement. These studies suggest that engage-and it has been suggested that SOCS-1 can serve as a
ment of GITR on CD25 suppressor cells in the presencenegative regulator of IFN/STAT1 (Yasukawa et al.,
of limiting amounts of IL-2 results in the abrogation of2000). Indeed, SOCS-1/ mice were found to have con-
stitutive activation of STAT1 resulting in hyperrespon- suppressor cell function. In the presence of IL-2, how-
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Biotinylated Hamster anti-4-1BB (clone 17B5) was purchased fromever, GITR engagement does not permanently prevent
eBioscience (San Diego, CA). FITC labeled Donkey anti-Goat wasthe induction of their suppressive activity.
purchased from Jackson ImmunoResearch Laboratories (WestAlthough two groups have identified a ligand for hu-
Grove, PA). Anti-CD8 and anti-PE magnetic beads were purchased
man GITR, the murine GITR-L has not been cloned. The from Miltenyi (Auburn, CA).
human GITR-L was not expressed by unstimulated or
stimulated T or B cells, but was expressed in umbilical Cell Purification, Stimulation, and RNA Isolation
vein endothelial cells (Gurney et al., 1999). It has there- Peripheral lymph nodes (axillary, inguinal, salivary, and mesenteric)
were harvested from 6- to 8-week-old female BALB/c or HA Tgfore been postulated that GITR/GITR-L interactions are
mice. In brief, T cells were purified using T cell enrichment columnsimportant in the interaction of lymphocytes with the vas-
(R&D Systems), and then depleted of CD8 cells by incubation withcular endothelium. However, it is possible that the mu-
anti-CD8 microbeads followed by sensitive depletion on AutoMACS
rine GITR-L is expressed on other cell types including (Miltenyi). CD8 T cells were incubated with PE labeled anti-CD25
subpopulations of antigen-presenting cells or responder (PC61) for 20 min, washed, and incubated with anti-PE microbeads
T cells. Induction of GITR-L expression during a rigorous for 15 min and purified by double column positive selection on
AutoMACS. Purity was confirmed by flow cytometry. CD4CD25inflammatory response to a pathogen may be necessary
and CD4CD25 cells were greater than 98% and 96%, respectively,to regulate the suppressive activity of CD4CD25
with no CD8 cell contamination. All CD4CD25 cells were testedT cells in a situation requiring a vigorous effector im-
in a suppression assay immediately or after preactivation to assess
mune response. their suppressive function. FACS was also used for purification of
As CD4CD25 T cells have recently been identified cells. Lymph node cells were incubated with appropriate amounts
in human thymus and peripheral blood and appear to of TC labeled anti-CD4, PE labeled anti-CD25, and for some applica-
tions biotinylated anti-CD103 followed by SA-FITC. CD4CD25 andclosely resemble their murine counterparts in all their
CD4CD25 T cells were selected, and in addition CD4CD25 werefunctional properties in vitro (Shevach, 2001), one major
further separated using BD FACSVantage Turbo sorter based onissue that remains is the development of technologies
the highest and lowest 20% of CD103 expression. Sorter profiles
to therapeutically manipulate regulatory T cell function. for all populations are shown in Figure 4A.
The gene expression data presented here strongly sup- For cell stimulations, purified cells (106/ml) were cultured in com-
port the view that furthering our understanding of the plete RPMI/10% FBS supplemented with 100U/ml IL-2 at 37	C for
0, 12 or 48 hr in 24 well plates precoated with 5 g/ml anti-CD3.normal cellular physiology of regulatory T cells may yield
RNA was purified using RNeasy columns (Qiagen, Valencia, CA)important insights into how to control both their num-
according to manufacturer’s instructions. Flow cytometry was alsobers and functional activity in vivo. For example, inhibi-
performed using TC labeled anti-CD4, PE or FITC labeled anti-CD25
tion of the function of one of more of the SOCS family in combination with various antibodies indicated in Figure 4. Intra-
members expressed by the CD25 population may be cellular staining was performed to analyze CTLA-4 expression, by
needed to successfully expand the numbers of CD25 first incubating with TC labeled anti-CD4 and FITC labeled anti-
CD25. They were washed, fixed in 4% paraformaldehyde, andcells. The model we have proposed for the role of GITR
washed again in staining buffer containing 0.5% saponin. The cellsin regulating CD25 function suggests that enhancement
were then counterstained with PE labeled-anti-CTLA-4 in this sameof CD25 T cell-mediated suppression in autoimmunity,
buffer. Positive staining of each antibody was compared to staining
as well as downmodulation of CD25 T cell-mediated of its respective control antibody and analyzed using CellQuest
suppression in conjunction with development of vac- software (BDIS, San Jose, CA).
cines to tumors or infectious agents, may be achieved by
manipulating GITR/GITR-L interactions or modulating DNA Microarray Hybridization and Analysis
Ten micrograms of total RNA was quantitatively amplified and biotin-signaling through GITR or GITR-L.
labeled (Byrne et al., 2000). In brief, RNA was converted to double-
stranded cDNA using an oligo dT primer that has a T7 RNA polymer-Experimental Procedures
ase site on the 5
 end (5
-GGCCAGTGAATTGTAATACGACTCACTA
TAGGGAGGCGG-(T24)-3
). The cDNA was then used directly in anMice, Antibodies, and Reagents
in vitro transcription reaction in the presence of biotinylated nucleo-BALB/c mice (6- to 8-week-old females) were purchased from NCI
tides Bio-11-UTP and Bio-11-CTP (Enzo, Farmingdale, NY). To im-Frederick animal facility. C57BL/6 (B6) mice (6- to 8-week-old fe-
prove hybridization kinetics, the labeled antisense RNA was frag-males) were purchased from Jackson (Bar Harbor, ME). B10.D2
mented by incubating at 94	C for 35 min in 30 mM MgOAc, 100expressing a transgenic TCR specific for HA(100-120) (HA Tg) (Kirberg
mM KOAc. Hybridization to Genechips (Affymetrix, San Jose, CA)et al., 1994) were purchased from the NIAID/Taconic Contract. All
displaying probes for 11,000 mouse genes/ESTs was performed atmice were housed in SPF conditions. PE labeled Rat anti-CD25
40	C overnight in a mix that included 10 g fragmented RNA, 6X(clone PC61), FITC labeled Rat anti-CD25 (clone 7D4), FITC labeled
SSPE, 0.005% Triton X-100, and 100 g/ml herring sperm DNA inRat anti-CD8a (clone 53-6.7), purified Hamster anti-CD28 (clone
a total volume of 200 l. Chips were washed, stained with SA-PE,37.51), FITC or PE labeled Rat anti-Ly6 family members (Ly6A/E,
and read using an Affymetrix Genechip scanner and accompanyingSca-1 clone D7; Ly6C clone AL-21; Ly6D, ThB clone 49-H4; Ly6G,
gene expression software. Labeled bacterial RNAs of known con-Gr-1 clone RB6-8C5; Sca-2, Ly-6E, clone MTS35), purified and bio-
centration were spiked into each chip hybridization mix to generatetinylated Rat anti-CD103 (integrin IEL, clone M290), purified Ham-
an internal standard curve, allowing normalization between chipsster anti-CD3e (clone 145-2C11), purified and PE labeled Hamster
and conversion of raw hybridization intensity values to mRNA fre-anti-CTLA-4 (CD152, clone UC10-4F10-11), purified Rat anti-OX40
quency (mRNA molecules per million). Chip sensitivity for RNA de-(CD134, clone OX-86), purified Hamster anti-4-1BB (CDw137, clone
tection in each run was determined to be 5 RNA molecules/106.1AH2), purified Rat anti-CD2 (LFA-2, clone RM2-5) and Streptavidin
(SA)-FITC and -PE and all the directly labeled or biotinylated-isotype
controls were purchased from PharMingen (San Diego, CA). Purified In Vitro Proliferation Assays
Suppression assays were performed as previously describedand FITC labeled Rat anti-OX40 (clone OX-86) were purchased from
Serotec (Oxford, United Kingdom). Tri-Color labeled Rat anti-CD4 (Thornton and Shevach, 1998; Piccirillo and Shevach, 2001). Also,
BALB/c CD4CD25 T cells (106/ml) were prestimulated for a mini-(clone CT-CD4) was purchased from Caltag (Burlingame, CA). Nor-
mal goat IgG (control Ig), purified polyclonal Goat anti-GITR, puri- mum of 3 days in 24-well plates with 0.5 g/ml soluble anti-CD3 in
the presence of 100 U/ml rIL-2, irradiated T cell depleted spleno-fied Rat anti-IL-17 (clone 50104.11), and purified polyclonal Goat
anti-IL-17R were purchased from R&D Systems (Minneapolis, MN). cytes with or without anti-GITR or control Goat IgG. These activated
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CD4CD25 cells were used in suppression assays as described interactions: A role of CD40 in regulatory T cell development. J.
Immunol. 166, 353–360.(Thornton and Shevach, 2000). All cultures were pulsed with 1 Ci
3H-thymdine for the last 6–12 hr of 65–72 hr cultures. Lechner, O., Lauber, J., Franzke, A., Sarukhan, A., von Boehmer,
H., and Buer, J. (2001). Fingerprints of anergic T cells. Curr. Biol.
Received August 20, 2001; revised January 25, 2002. 11, 587–595.
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